Eli Lilly, a global pharmaceutical company, has launched Mounjaro (tirzepatide) in India. This new therapeutic is important for individuals struggling with obesity and type 2 diabetes (T2D). Mounjaro comes in a once-weekly injection in dosage strengths of 2.5 mg, 5 mg and more. Mounjaro 2.5 mg/5 mg injection helps control blood sugar and promotes weight loss. It is designed to work by targeting two very important hormones in the body that help control glucose levels as well as appetite.
What is Mounjaro?
The medicine Mounjaro 2.5 mg/5 mg is designed to help manage type 2 diabetes (T2D) and obesity. It works by affecting hormones known as GIP and GLP-1, which play an important role in regulating blood sugar and reducing hunger. This makes losing weight easier as well as dealing with diabetes easier.How Much Does Mounjaro Cost in India?
Eli Lilly has set a price that as of now appears to be reasonable in the Indian market. The costs of Mounjaro 2.5 mg/5 mg in India are as follows: 2.5 mg vial: ₹3,500 5 mg vial: ₹4,375 Such pricing is bound to make Mounjaro easily accessible for any person undergoing issues of weight gain and diabetes.How Effective is Mounjaro?
Mounjaro has provided amazing results in clinical trials. During one of the trials called the SURMOUNT-1 trial, the participants who were at the highest dose of Mounjaro at least lost an average of 20.9% of their body weight in a duration of 72 weeks. Moreover, the SURPASS program proved that Mounjaro aids in aiding patients suffering from type 2 diabetes in managing their blood sugar levels more efficiently.Why is Mounjaro Important for India?
India has major health concerns regarding obesity and diabetes. Obesity: Close to 100 million people are suffering from obesity in India which amounts to almost 6.5% of the adult population. Diabetes: The number of diabetic patients in India is pegged at 101 million. For those suffering from these ailments, Mounjaro 2.5 mg/5 mg injection is a major hope. It can aid in weight reduction and blood sugar management which helps lower the chances of getting heart diseases, high blood pressure, and even sleep apnea.What’s Next for Mounjaro in India?
The launch of Mounjaro 2.5 mg/5 mg in India is only the start. Other pharmaceutical companies such as Novo Nordisk are hoping to introduce their weight loss pills in India in the next few years. This has a positive impact on the country as people suffering from obesity and diabetes will have more treatment alternatives available to them.Consult Your Doctor:
Make sure to consult a medical professional before using Mounjaro 2.5 mg/5 mg injection. As with all medicine, Mounjaro carries the possibility of side effects, which is why a healthcare provider (HCP) will help make sure that it is a good option for you. Eli Lilly’s introduction of Mounjaro in India marks a game-changing milestone in combating obesity and diabetes. With the new medicine, people are now equipped with an effective weapon to help them live healthier lives. Disclaimer: This blog is for informational purposes only. Always talk to your healthcare provider before starting any new medication.References:
https://uspl.lilly.com/mounjaro/mounjaro.html
https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-mounjarotm-tirzepatide-injection-first-and
https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management